| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.06 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |